AI & ChatGPT searches , social queries for SURVODUTIDE
Search references for SURVODUTIDE. Phrases containing SURVODUTIDE
See searches and references containing SURVODUTIDE!
Search references for SURVODUTIDE. Phrases containing SURVODUTIDE
See searches and references containing SURVODUTIDE!SURVODUTIDE
Peptide drug
Survodutide (BI 456906) is an experimental peptide that works as a dual glucagon/GLP-1 receptor agonist. Unlike other dual GLP-1/glucagon dual agonists
Survodutide
Receptor activated by peptide hormone GLP-1
apraglutide maridebart cafraglutide tirzepatide pegapamodutide mazdutide survodutide bamadutide pemvidutide cotadutide retatrutide Lithium chloride Cinchonine
Glucagon-like peptide-1 receptor
Glucagon-like_peptide-1_receptor
Excessive fat buildup in the liver with other metabolic disease
(moderate or severe) fibrosis when given once-weekly for 52 weeks, while survodutide decreased liver fat content and improved fibrosis compared to placebo
Metabolic dysfunction–associated steatotic liver disease
Metabolic_dysfunction–associated_steatotic_liver_disease
Class of pharmacological agents
agonist In phase 3 clinical trials 14.7 percent in a phase II trial. Survodutide Dual GLP-1 and GIP receptor agonist In phase 3 clinical trials 16.6 percent
Anti-obesity_medication
SURVODUTIDE
SURVODUTIDE
SURVODUTIDE
SURVODUTIDE
SURVODUTIDE
SURVODUTIDE
SURVODUTIDE
SURVODUTIDE
SURVODUTIDE